Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo-Reference-Cited by-同舟云学术

Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo

Published:2023-05 Issue: Volume:120-121 Page:108351
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Wichmann Christian W.,Poniger Stan,Guo Nancy,Roselt Peter,Rudd Stacey E.,Donnelly Paul S.,Blyth Benjamin,Van Zuylekom Jessica,Rigopoulos Angela,Burvenich Ingrid J.G.,Morandeau Laurence,Mohamed Shifaza,Nowak Anna K.,Hegi-Johnson Fiona,MacManus Michael,Scott Andrew M.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference27 articles.

1. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

2. Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression;Ferris;Oral Oncol,2018

3. Overall survival with combined nivolumab and ipilimumab in advanced melanoma;Wolchok;N Engl J Med,2017

4. Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer;Antonia;N Engl J Med,2017

5. Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET;Chomet;Eur J Nucl Med Mol Imaging,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automated radiolabeling and handling of ¹⁷⁷Lu‐ and ²²⁵Ac‐PSMA‐617 using a robotic pipettor;Journal of Labelled Compounds and Radiopharmaceuticals;2024-01-31